Purchase Order 75P00226P00005
- Not listed
- The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a $172,232 firm fixed-price purchase order to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 6, 2026, for Japanese encephalitis vaccine to protect State Department personnel and their families. The contract carries a total small business set-aside designation and is scheduled for completion by January 6, 2026, with performance taking place in Bethesda, Maryland. Valneva USA is a...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Valneva USA, Inc. - doing business as Intercell USA Inc. - to provide Japanese encephalitis vaccine. The contract has a potential value of $190,690.00 and a completion date of February 14, 2022. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, holds multiple indefinite-delivery/indefinite-quantity contracts with the Defense Logistics Agency...
- This is a firm fixed-price delivery order awarded by the Bureau of Medical Services, a civilian agency, to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization. The order is for the supply of the IXIARO Japanese encephalitis vaccine, with an ultimate completion date of September 30, 2024 and a ceiling value of $56,646.00. The contract was issued under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule...
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the Japanese Encephalitis Vaccine (IXIARO). The $237,264.00 contract, which has no set-aside designation, will be performed in Bethesda, Maryland and runs through April 19, 2024. Valneva USA, Inc. is a subsidiary of the specialty vaccine company Valneva SE, which develops and manufactures vaccines to address...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of Valneva SE, for the provision of the Japanese Encephalitis Virus Vaccine (IXIARO). This $249,648.00 firm fixed price contract has a completion date of March 25, 2025 and was awarded on March 26, 2024. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a set-aside...
- This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Valneva USA, Inc. (dba Intercell USA Inc.), a foreign-owned for-profit organization. The $18,760.75 order is for the supply of the Japanese encephalitis vaccine IXIARO, which is being delivered against Valneva USA's General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. This order has an ultimate completion date of...
- This is a federal contract award to Valneva USA, Inc., doing business as Intercell USA Inc., for the supply of the IXIARO Japanese encephalitis vaccine. The $86,608.50 fixed-price purchase order was awarded on February 25, 2016 by the Office of the Assistant Secretary for Administration, a civilian federal agency. The contract has a completion date of March 11, 2016 and was not set aside for any specific business type. Valneva USA is a foreign-owned, for-profit organization that specializes in...
- Valneva USA, Inc. (doing business as Intercell USA Inc.) was awarded a $710,457 firm fixed-price delivery order by the Department of Veterans Affairs, Veterans Integrated Service Network 12, on November 1, 2025, for the supply of Japanese Encephalitis Virus Vaccine IXIARO. The contract is scheduled for completion by September 30, 2026, with performance taking place in Bethesda, Maryland. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and...
- This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Valneva USA, Inc., which does business as Intercell USA Inc. The contract is for the supply of the IXIARO vaccine, a Japanese encephalitis vaccine, with a firm fixed price of $130,235.00 and a completion date of June 15, 2019. The contract is not set aside and is issued under Valneva USA's General Services Administration Schedule 61-IB contract for...
The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a $174,976 firm fixed-price purchase order to Valneva USA, Inc. (doing business as Intercell USA Inc.) for Japanese encephalitis vaccine on January 12, 2026. The contract, designated as a Total Small Business set-aside, calls for delivery to Bethesda, Maryland, with an ultimate completion date of January 12, 2026. Valneva USA, a subsidiary of French vaccine manufacturer Valneva SE, is a established supplier of the IXIARO Japanese encephalitis vaccine to multiple federal agencies, including the Department of Defense, Department of Veterans Affairs, and Department of Health and Human Services. This award represents a discrete purchase order under Valneva USA's existing federal contracting relationships. The company maintains significant Indefinite Delivery Contracts with the Defense Logistics Agency Troop Support Medical valued at over $97 million combined, as well as a Federal Supply Schedule contract with the Department of Veterans Affairs valued at approximately $4 million through September 2030. The State Department's procurement supports the agency's mission to protect personnel deployed internationally or working in areas where Japanese encephalitis poses a health risk, aligning with broader federal government vaccine supply initiatives for critical medical countermeasures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $175.0k | 1/12/26 |